European Archives - Page 1173 of 1220 - European Medical Journal

Multiple Myeloma and Renal Failure

Renal failure (RF) occurs in approximately 20-30% of multiple myeloma (MM) patients at diagnosis and in more than 50% of patients with advanced disease.

Checkpoint Blockade in Cancer Immunotherapy: Squaring the Circle

Manipulating the complex interaction between the immune system and tumour cells has been the focus of cancer research for many years, but it is only in…

How I Treat: Prognostication in Chronic Lymphocytic Leukaemia: A Gaze into the Future

Chronic lymphocytic leukaemia (CLL) is due to the relentless accumulation of monoclonal B lymphocytes with a distinct immunophenotype…

EMJ Oncology 3.1 2015

Hello, and a very warm welcome to this edition of European Medical Journal Oncology, the first of two volumes this year.

EMJ

ESMO 2014: The collaboration between UCL and the Francis Crick Institute

At ESMO 2014, Prof Jonathan Ledermann (UCL, UK) discusses the collaboration between UCL and the Francis Crick Institute that is hoped to increase the…

EMJ

Asthma No Lung-er a Problem for Premature Babies

PREMATURE babies are more likely to develop asthma at a young age than other children, although they will grow out of it later in life, a study has shown.

EMJ

Lung Cancer Projected to Be Leading Cause of Cancer Death in EU Women

LUNG cancer is predicted to become the leading cause of death by cancer for women in Europe this year, surpassing the number of deaths caused by…

EMJ

ESMO 2014: Inhibition of PARP, angiogenesis and immune checkpoints for ovarian cancer management

At ESMO 2014, Prof Jonathan Ledermann (University College London, UK) provides an update on the management of ovarian cancer, including maintenance…

EMJ

Below the Belt, Experiences with Prostate Cancer

There is a new guy on the block. A new guy in the guise of a book written by new-age men talking about their very own personal experiences of their…

EMJ

Basilea Reports U.S. FDA Approval of Isavuconazole for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis

Basel, Switzerland, March 9, 2015 – Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the U.S. Food and Drug Administration (FDA) approved…